Daily Archives: July 17, 2017

RedHill Biopharma Announces Last Patient Visit in BEKINDA® Phase II Study for IBS-D

Top-line results are expected in September 2017 The randomized, double-blind, placebo-controlled Phase II study is evaluating the safety and efficacy of BEKINDA® (RHB-102) 12 mg in 127 U.S. patients with diarrhea-predominant irritable bowel syndrome (IBS-D), with a primary endpoint of

The Nigerian Stock Exchange Goes Live with Nasdaq SMARTS Market Surveillance Technology

LAGOS, Nigeria and STOCKHOLM, Sweden, July 17, 2017 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq:NDAQ) and The Nigerian Stock Exchange (NSE) have officially announced that NSE, the stock exchange of the largest economy in Africa, has launched a new market surveillance platform powered